The surgeon's ego and reporting of clinical failure

H. Kaafarani,K. Itani
DOI: https://doi.org/10.1002/bjs.4926
2005-01-01
Abstract:Sir The report in BJS was our preliminary experience, and has now been confirmed in a larger group of patients. In addition, we have found CEIOUS useful for differentiating liver nodules found during surgery for hepatocellular carcinoma in patients with liver cirrhosis and in guiding the surgeon’s hand during liver dissection1. The European Medicines Agency (EMEA) did indeed temporarily withdraw approval for SonoVue but, as specified, this was for its cardiac use only. The risks are now better defined and caution should be used in patients with severe cardiac disease. This may have particular relevance for outpatients. Patients admitted for liver surgery have routine evaluation of anaesthetic, respiratory and cardiac risks; moreover they have real-time monitoring during the surgical procedure. These considerations make the intra-operative use of Sonovue safe in clinical practice. G. Torzilli Istituto Clinico Humanitas, University of Milan, Milan, Italy DOI: 10.1002/bjs.4925
What problem does this paper attempt to address?